Zdrowie i gospodarka · 25/05/2023
FDA Clears Levobupivacaine Injection for Sale
The FDA has determined that Chirocaine (levobupivacaine) injection, 2.5mg/mL, 10mL and 30mL vials, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications for these products.